Telangana to establish B-Hub for biopharma manufacturing at Genome Valley
The Telangana government today said it plans to establish a B-Hub at Genome Valley here to scale up manufacturing activities for biopharma based Research and Development.
The proposed B-Hub, with at an estimated cost of Rs 60 crore, would be set up through Public Private Partnership (PPP) in Genome Valley, India's first organized cluster for life sciences Research & Development and clean manufacturing activities, an official release said.
"B-Hub will be a first of its kind initiative in the country, aimed at providing much-needed support to the biopharma R&D activities, featuring a scale-up manufacturing facility, along with a turnkey incubator/lab space module at Good Laboratory Practises grade within a built-up area of 40,000 square feet," it said.
Establishment of an end-to-end biopharma scale-up manufacturing facility would give domestic companies the required impetus viz-a-viz Korea, China and France who have taken lead in biopharma innovation, it added.
Companies in early-stage clinical development, but lacking the requisite expertise and resources to navigate the complexities associated with business planning, cell line development, process development, technology, and/or regulatory and risk assessment, can leverage B-Hub facility to help break down roadblocks and improve the likelihood of commercial success, the release said.
Meanwhile Telangana Minister for IT and Industries K T Rama Rao today launched a web portal for the life sciences sector, aimed at creating an interface between the government, Industries, Research Institutions and Start-ups, a separate release said.
Telangana, which has emerged as the 'Pharma capital of India', has set out an ambitious vision for the sector, through leveraging its existing strengths, to create four lakh jobs at an investment of USD 100 Billion in the next 10 years, it said.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)